Increased plasma LIGHT levels in patients with atopic dermatitis

Clinical and Experimental Immunology

Volumn 168, Issue 3, 2012, Pages 318-324

  Kotani, H ^a   Masuda, K ^a   Tamagawa Mineoka, R ^a   Nomiyama, T ^a   Soga, F ^a   Nin, M ^a   Asai, J ^a   Kishimoto, S ^a   Katoh, N ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Atopic dermatitis; LIGHT; THP 1

Indexed keywords

BIOLOGICAL MARKER; CASPASE 3; IMMUNOGLOBULIN E; LACTATE DEHYDROGENASE; MEMBRANE PROTEIN; PROTEIN BCL 2; PROTEIN LIGHT; RECOMBINANT PROTEIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; ATOPIC DERMATITIS; BLOOD LEVEL; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL COUNT; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; MALE; MONOCYTE; PATCH TEST; PATHOGENESIS; PLASMA; PRIORITY JOURNAL; SCORING SYSTEM; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADULT; ANTIGENS, CD86; APOPTOSIS; BIOLOGICAL MARKERS; CELL LINE, TUMOR; CHEMOKINE CCL17; DERMATITIS, ATOPIC; DISEASE PROGRESSION; EOSINOPHILS; FEMALE; HUMANS; IMMUNOGLOBULIN E; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; MONOCYTES; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14; UP-REGULATION; YOUNG ADULT;

EID: 84859951747     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2012.04576.x     Document Type: Article

References (36)

1. Marui DN, Ebner R, Montgomery RI etal. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpes virus entry mediator. Immunity 1998; 8:21-30.
2. Harrop JA, McDonnell PC, Brigham-Burke M etal. Herpes virus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth. J Biol Chem 1998; 273:27548-56.
3. Morel Y, Schiano de Colella JM, Harrop J etal. Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT down-regulates its own receptor. J Immunol 2000; 165:4397-404.
4. Tamada K, Shimozaki K, Chapoval AI etal. LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J Immunol 2000; 164:4105-10.
5. Granger SW, Rickert S. LIGHT-HVEM signaling and the regulation of T cell-mediated immunity. Cytokine Growth Factor Rev 2003; 14:289-96.
6. Otterdal K, Smith C, Oie E etal. Platelet-derived LIGHT induces inflammatory responses in endothelial cells and monocytes. Blood 2006; 108:928-35.
7. Kim WJ, Kang YJ, Koh EM, Ahn KS, Cha HS, Lee WH. LIGHT is involved in the pathogenesis of rheumatoid arthritis by inducing the expression of pro-inflammatory cytokines and MMP-9 in macrophages. Immunology 2005; 114:272-9.
8. Haroon N, Tsui FW, O'Shea FD etal. From gene expression to serum proteins: biomarker discovery in ankylosing spondylitis. Ann Rheum Dis 2010; 69:297-300.
9. Wang YG, Kim KD, Wang J, Yu P, Fu YX. Stimulating lymphotoxin beta receptor on the dendritic cells is critical for their homeostasis and expansion. J Immunol 2005; 175:6997-7002.
10. Bieber T. Atopic dermatitis. Ann Dermatol 2010; 22:125-34.
11. Nakazawa M, Sugi N, Kawaguchi H, Ishii N, Nakajima H, Minami M. Predominance of type 2 cytokine-producing CD4+ and CD8+ cells in patients with atopic dermatitis. J Allergy Clin Immunol 1997; 99:673-82.
12. Koga C, Kabashima K, Shiraishi N, Kobayashi M, Tokura Y. Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol 2008; 128:2625-30.
13. + T cells are recruited early to allergen exposure sites in atopy patch test reactions in human atopic dermatitis. J Allergy Clin Immunol 2011; 127:1064-7.
14. Kwon BS, Tan KB, Ni J etal. A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J Biol Chem 1997; 272:14272-6.
15. Harrop JA, Reddy M, Dede K etal. Antibodies to TR2 (herpes virus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines. J Immunol 1998; 161:1786-94.
16. Jung HW, La SJ, Kim JY etal. High levels of soluble herpes virus entry mediator in sera of patients with allergic and autoimmune diseases. Exp Mol Med 2003; 35:501-8.
17. Crowe PD, VanArsdale TL, Walter BN etal. A lymphotoxin-beta-specific receptor. Science 1994; 264:707-10.
18. Murphy M, Walter BN, Pike-Nobile L etal. Expression of the lymphotoxin beta receptor on follicular stromal cells in human lymphoid tissues. Cell Death Differ 1998; 5:497-505.
19. Watts TH. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 2005; 23:23-68.
20. Murphy KM, Nelson CA, Sedý JR. Balancing co-stimulation and inhibition with BTLA and HVEM. Nat Rev Immunol 2006; 6:671-81.
21. Ware CF. Network communications: lymphotoxins, LIGHT, and TNF. Annu Rev Immunol 2005; 23:787-819.
22. Duhen T, Pasero C, Mallet F, Barbarat B, Olive D, Costello RT. LIGHT costimulates CD40 triggering and induces immunoglobulin secretion; a novel key partner in T cell-dependent B cell terminal differentiation. Eur J Immunol 2004; 34:3534-41.
23. Xu G, Liu D, Okwor I etal. LIGHT is critical for IL-12 production by dendritic cells, optimal CD4+ Th1 cell response, and resistance to Leishmania major. J Immunol 2007; 179:6901-9.
24. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980; 92:44-7.
25. Nara K, Kusafuka T, Yoneda A, Oue T, Sangkhathat S, Fukuzawa M. Silencing of MYCN by RNA interference induces growth inhibition, apoptotic activity and cell diffrentiation in a neuro blastoma cell line with MYCN amplication. Int J Oncol 2007; 30:1189-96.
26. Lagasse E, Weissman IL. Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 1997; 89:1021-31.
27. Yang E, Korsmeyer SJ. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 1996; 88:386-401.
28. Green DR. Apoptotic pathways:the roads to ruin. Cell 1998; 94:695-8.
29. Kakinuma T, Nakamura K, Wakugawa M etal. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001; 107:535-41.
30. Katoh N. Platelets as versatile regulators of cutaneous inflammation. J Dermatol Sci 2009; 53:89-95.
31. Bratton DL, Hamid Q, Boguniewicz M, Doherty DE, Kailey JM, Leung DY. Granulocyte macrophage colony-stimulating factor contributes to enhanced monocytes survival in chronic atopic dermatitis. J Clin Invest 1995; 95:211-18.
32. Cai G, Wang H, Qin Q etal. Amelioration of myocarditis by HVEM-overexpressing dendritic cells through induction of IL-10-producing cells. Cardiovasc Res 2009; 84:425-33.
33. Katoh N, Kraft S, Wessendorf JH, Bieber T. The high-affinity IgE receptor (FcεRI) blocks apoptosis in normal human monocytes. J Clin Invest 2000; 105:183-90.
34. Schneider K, Potter KG, Ware CF. Lymphotoxin and LIGHT signaling pathways and target genes. Immunol Rev 2004; 202:49-66.
35. Lo JC, Wang Y, Tumanov AV etal. Lymphotoxin receptor-dependent control of lipid homeostasis. Science 2007; 316:285-8.
36. Kusunoki T, Morimoto T, Nishikomori R etal. Obesity and the prevalence of allergic diseases in schoolchildren. Pediatr Allergy Immunol 2008; 19:527-34.